Cibc Private Wealth Group, LLC Exact Sciences Corp Transaction History

Cibc Private Wealth Group, LLC

  • $52.7 Billion
  • Q4 2024

A detailed history of Cibc Private Wealth Group, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 3,357 shares of EXAS stock, worth $160,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,357
Previous 3,783 11.26%
Holding current value
$160,531
Previous $257,000 26.85%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$49.33 - $71.97 $21,014 - $30,659
-426 Reduced 11.26%
3,357 $188,000
Q3 2024

Nov 13, 2024
SELL
$42.43 - $70.83 $9,037 - $15,086
-213 Reduced 5.33%
3,783 $257,000
Q2 2024

Aug 09, 2024
SELL
$41.33 - $74.26 $3,058 - $5,495
-74 Reduced 1.82%
3,996 $168,000
Q1 2024

May 10, 2024
BUY
$56.27 - $73.77 $6,752 - $8,852
120 Added 3.04%
4,070 $281,000
Q4 2023

Feb 13, 2024
BUY
$59.06 - $75.72 $233,287 - $299,094
3,950 New
3,950 $292,000
Q3 2023

Nov 13, 2023
BUY
$65.94 - $99.04 $258,550 - $388,335
3,921 New
3,921 $267,000
Q2 2023

Nov 21, 2023
BUY
$62.68 - $95.05 $139,588 - $211,676
2,227 New
2,227 $209,000
Q2 2023

Aug 10, 2023
BUY
$62.68 - $95.05 $139,588 - $211,676
2,227 New
2,227 $209,000
Q2 2022

Aug 03, 2022
SELL
$35.61 - $76.23 $230,895 - $494,275
-6,484 Reduced 99.54%
30 $1,000
Q1 2022

May 16, 2022
SELL
$57.56 - $82.54 $14,447 - $20,717
-251 Reduced 3.71%
6,514 $455,000
Q4 2021

Feb 08, 2022
SELL
$72.5 - $100.68 $17.7 Million - $24.6 Million
-244,804 Reduced 97.31%
6,765 $527,000
Q3 2021

Nov 12, 2021
BUY
$90.24 - $124.05 $3.4 Million - $4.68 Million
37,700 Added 17.63%
251,569 $24 Million
Q2 2021

Aug 16, 2021
SELL
$93.66 - $139.27 $465,396 - $692,032
-4,969 Reduced 2.27%
213,869 $26.6 Million
Q1 2021

May 12, 2021
SELL
$116.57 - $155.01 $1.02 Million - $1.35 Million
-8,718 Reduced 3.83%
218,838 $28.8 Million
Q4 2020

Feb 12, 2021
SELL
$99.61 - $142.12 $430,713 - $614,526
-4,324 Reduced 1.86%
227,556 $30.1 Million
Q3 2020

Nov 03, 2020
BUY
$72.92 - $102.01 $16.9 Million - $23.7 Million
231,880 New
231,880 $23.6 Million
Q3 2020

Oct 29, 2020
SELL
$72.92 - $102.01 $16.7 Million - $23.3 Million
-228,433 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$55.75 - $92.75 $637,445 - $1.06 Million
-11,434 Reduced 4.77%
228,433 $19.9 Million
Q1 2020

May 15, 2020
SELL
$37.9 - $104.44 $267,990 - $738,495
-7,071 Reduced 2.86%
239,867 $13.9 Million
Q4 2019

Jan 30, 2020
SELL
$77.66 - $99.74 $701,813 - $901,350
-9,037 Reduced 3.53%
246,938 $22.8 Million
Q3 2019

Oct 16, 2019
SELL
$90.37 - $122.49 $68.3 Million - $92.5 Million
-755,246 Reduced 74.69%
255,975 $23.1 Million
Q2 2019

Jul 31, 2019
SELL
$89.51 - $118.04 $3.42 Million - $4.51 Million
-38,241 Reduced 3.64%
1,011,221 $119 Million
Q1 2019

May 10, 2019
BUY
$61.98 - $96.5 $8.73 Million - $13.6 Million
140,825 Added 15.5%
1,049,462 $90.9 Million
Q4 2018

Feb 05, 2019
SELL
$56.04 - $82.66 $10.7 Million - $15.8 Million
-190,930 Reduced 17.36%
908,637 $57.3 Million
Q3 2018

Nov 14, 2018
SELL
$48.29 - $80.6 $365,507 - $610,061
-7,569 Reduced 0.68%
1,099,567 $86.8 Million
Q2 2018

Aug 02, 2018
BUY
$37.84 - $69.96 $18.2 Million - $33.7 Million
481,230 Added 76.89%
1,107,136 $66.2 Million
Q1 2018

May 17, 2018
BUY
$39.82 - $57.53 $20.2 Million - $29.1 Million
506,404 Added 423.76%
625,906 $25.2 Million
Q4 2017

Feb 12, 2018
BUY
$46.49 - $60.51 $5.56 Million - $7.23 Million
119,502
119,502 $6.28 Million

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
164M
Call Options Held
4.25M
Put Options Held
1.89M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.46B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email